Patologie del cuoio capelluto

Translated title of the contribution: Scalp disorders

Antonio Di Maio, Damiano Abeni, Gianfranco Altomare, Enzo Berardesca, Piergiacomo Calzavara Pinton, Clara De Simone, Alberto Giannetti, Paolo Gisondi, Torello Lotti, Stefano Piaserico, Rosita Saraceno, Gino Antonio Vena

Research output: Contribution to journalArticlepeer-review


An international meeting on scalp disorders was recently held in Rome. Psoriasis, seborrheic dermatitis, sebopsoriasis and primary cicatricial alopecias were the main topics. In this circumstance the results of the clinical trials in scalp psoriasis with a new fixed combination containing calcipotriene 50 μg/g and betamethasone (0.5 mg/g) as dipropionate in lipophilic gel (Xamiol®) were shown. Calcipotriene plus betamethasone dipropionate gel is a fast-acting, very efficacious, safe, oncedaily treatment for scalp psoriasis ranging from mild to very severe. It is more efficacious than calcipotriene, betamethasone dipropionate and the gel vehicle. The safety profile is similar to that of betamethasone dipropionate and better than calcipotriol. Two 52-week studies have shown that calcipotriene plus betamethasone dipropionate gel can be safely used longterm.

Translated title of the contributionScalp disorders
Original languageItalian
Pages (from-to)71-81
Number of pages11
JournalJournal of Plastic Dermatology
Issue number1
Publication statusPublished - 2010

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'Scalp disorders'. Together they form a unique fingerprint.

Cite this